Stock · WAT · Healthcare

Waters Corporation

United States · Large Cap · listed since 1995 · Revenue 12 mo. $4.6B

Price as of 11/06/2026

StockScorer score
4.5
of 10 5 of 11 points Low Match To the score
Price
$457.60
1 Y +13.7%
Market cap
$46.2B
Phase
Mature
core business profitable, revenue barely moving
Revenue +2.1% a year (3 years)EBIT margin 28.2%Payout 2.2% of operating cash flow

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.

moreless

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Original text from the data provider

Summary

Waters Corporation is around the middle of the Healthcare sector overall

44.7 of 100

Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.

Analysis

What the price requires

The price requires 28.6% FCF growth a year, more than achieved over the last 5 and 10 years.

If free cash flow stays at €484.4M (2025), it supports €5.4B. The remaining €36.1B of the market value assume it grows 28.6% a year for 10 years and not at all afterwards.

Required FCF growth per year

28.6%

no growth afterwards

Market value breakdown€41.5B market value, price as of 11/06/2026

€5.4B without growth
€36.1B priced-in growth
  • 5 yrs achieved −0.5%
  • 10 yrs achieved 0.0%
  • priced in 28.6%

Valuation against its own history

Price to operating cash flow 81.7×, above its usual range.

Middle half of 20 quarters: 27.7× to 31.5×, median 29.0×.

Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.

1 sign supports the expectation, 1 speaks against it.

What supports it

with respect to the priced-in expectation

  • High, stable gross margin median 58.7%, range 2.1 pp (10 years)

What speaks against it

with respect to the priced-in expectation

  • Expectation above the company's own record priced in 28.6%, achieved at most 0.0%

Since the last quarter

Q1 → Q2 2026

A mixed quarter: 3 figures better, 3 worse.

  • Revenue, 12 mo.$3.8B → $4.6B+23.2%better
  • FCF, 12 mo.$264.0M → $398.5M+50.9%better
  • Gross margin55.0% → 50.8%−4.2 ppworse
  • EBIT margin17.1% → 8.0%−9.1 ppworse
  • FCF margin7.0% → 8.6%+1.6 ppbetter
  • Shares outstanding82.1M → 98.2M+19.6%worse

2 more unchanged: Net debt, Return on equity

Derivation

How the sector comparison is derived

Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.

Price as of 11/06/2026.

Profitability68.6above the middleEarns more than the sector: Return on equity 25.09%, sector 11.52%.
MetricStockSector medianPosition in sector
Return on equity25.09%11.52%Rank 84
Return on capital (Greenblatt)54.77%32.55%Rank 72
EBIT margin28.22%18.31%Rank 80
FCF margin17.05%14.12%Rank 61
Gross margin57.77%60.99%Rank 46
Growth40.7around the middleGrows about as fast as the sector.
MetricStockSector medianPosition in sector
Revenue growth, 1 year6.99%8.04%Rank 45
Earnings growth, 3 years per year−2.83%5.44%Rank 29
Earnings growth, 5 years per year5.19%7.00%Rank 42
Sustainable growth (ROE × retained earnings)3.56%3.66%Rank 47
Valuation15.6below the middleValued higher than the sector: EV/EBIT 52.79, sector 21.73.
MetricStockSector medianPosition in sector
Earnings yield2.35%2.90%Rank 34
FCF yield1.17%3.63%Rank 14
EV/saleslower is better14.904.03Rank 8
EV/EBITlower is better52.7921.73Rank 6
Momentum59.2around the middleShare price moving about like the sector.
MetricStockSector medianPosition in sector
Share price, 1 year13.68%8.66%Rank 57
Share price, 6 months29.34%24.27%Rank 64
Share price, 3 months17.60%15.42%Rank 56
Distance from 52-week high−4.68%−7.35%Rank 61
Quality36.6below the middleQuality below the sector: Dividend streak in years –, sector 10.
MetricStockSector medianPosition in sector
Accruals (Sloan)lower is better2.96%0.30%Rank 28
Change in share countlower is better0.26%0.00%Rank 24
Dividend streak in years–10Rank 13
Price reaction to results, market-adjusted4.05%0.05%Rank 81
Balance sheet & risk47.5around the middleRisk about like the sector.
MetricStockSector medianPosition in sector
Equity ratio50.45%48.40%Rank 53
Net debt/EBITDAlower is better0.891.11Rank 55
Debt to equitylower is better0.580.48Rank 46
Volatility, 1 yearlower is better35.52%31.42%Rank 36

Ten years in figures

Revenue from $2.2B (2016) to $3.2B (2025), 4.3% a year.

Fiscal years, amounts in USD
YearRevenue, $BEBIT marginFCF, $MSharesNet debt
20162.228.8%534.181.4M$1.3B
20172.328.7%607.280.6M$1.4B
20182.430.6%476.977.6M$352.1M
20192.429.4%479.368.2M$1.3B
20202.427.3%618.162.4M$919.8M
20212.829.5%579.062.0M$1.0B
20223.029.4%428.260.3M$1.2B
20233.027.7%442.259.3M$2.0B
20243.027.9%619.659.6M$1.4B
20253.228.2%539.859.7M$903.3M
4.5 / 10Low MatchStockScorer score5 of 11 points

3 of 7 StockScorer Score rules met · How the score is built

Waters Corporation mainly meets criteria in the Profitability category. Result from 18 strategies checked.

This stock · Profitability: 100%This stock · Growth: 0%This stock · Valuation: 0%This stock · Momentum: 0%Median of all stocks · Profitability: 33%Median of all stocks · Growth: 0%Median of all stocks · Valuation: 0%Median of all stocks · Momentum: 0%50%100%ProfitabilityGrowthValuationMomentumThis stockMedian of all stocks

How Waters Corporation's score is built

Waters Corporation is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.

3 of 7 rules met

5 of 11 points

  1. Free cash flow yield above the sector mediannot met0 of 2 points
  2. Return on capital (Greenblatt ROC) above the sector medianmet2 of 2 points
  3. Return on equity above the sector medianmet1 of 1 point
  4. Free cash flow margin above the sector medianmet2 of 2 points
  5. Revenue growth above 15%not met0 of 2 points
  6. 3-year earnings growth above 12% p.a.not met0 of 1 point
  7. 12-month share price more than 20 percentage points ahead of the marketnot met0 of 1 point
  8. Exclusion: financial and real estate stocksdoes not apply

Detail data

How does Waters Corporation stock perform across 18 strategies?

Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.

12 more strategies locked

With a free account, you can see the match across all strategies checked in one complete overview.

  • Earnings Quality: Accrual Check (Sloan)
  • Defensive: Low Volatility
  • Levermann Strategy (13 Criteria)
  • Magic Formula: Value + Quality
  • Acquirer's Multiple: EV/EBIT Deep Value
  • Dividend Aristocrats & Continuity
  • Dividend Quality: 4 Factors
  • Balanced GARP
  • High-Growth / Rule of 40
  • PEG Strategy (inspired by Peter Lynch)
  • Trending Value: Value + Momentum
  • Undervalued Stocks: Multi-Factor Check

Waters Corporation key metrics: P/E, P/B and equity ratio

Selected fundamental metrics for Waters Corporation.

MetricStockSector
P/E ratio42.530.0
P/B ratio10.74.8
Return on equity (ROE)25.1%11.5%
Equity ratio50.5%48.4%
Debt-to-equity (D/E)0.580.48
Dividend yield0.0%1.3%

Similar stocks in Healthcare

How comparable stocks in the same sector score in the StockScorer model.

SymbolCompanyRating
WATWaters Corporationthis page
IQVIQVIA Holdings IncLow4.5
NTRANatera Inclocked
IDXXIDEXX Laboratories IncMedium5.5
AAgilent Technologies Inclocked
ILMNIllumina Inclocked

Frequently asked questions about Waters Corporation stock

How does Waters Corporation stock (WAT) score in the StockScorer model?
Waters Corporation stock reaches a StockScorer score of 4.5 out of 10, which is a low match with the rule-based strategies. 3 out of 7 flagship profile rules are met.
What is Waters Corporation's P/E ratio?
Waters Corporation's P/E ratio is 42.5. The Healthcare sector median is 30.0.
What sector is Waters Corporation in?
Waters Corporation is assigned to the Healthcare sector. Its rank within the sector is 44.7 out of 100: 100 means the stock leads its peer group of large and mid-cap sector stocks in every measured area.

Unlock the full analysis for free

Signed up in 30 seconds, free.

  • More metrics: FCF margin, cash flow yield and more
  • Full peer comparison within the same sector
  • See the match across all strategies in detail
  • Apply your own scoring profile to any stock
  • Add the stock to your watchlist and track score changes
  • Daily updated ratings, rule-based and transparent

Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.

How StockScorer rates every stock is explained on the methodology page.